[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$sgmt Graphic $sgmt

$SGMT sees a surge in engagement as traders celebrate profits from stock picks. Positive sentiment dominates despite some FUD, with creators and investors sharing profitable strategies.

About $sgmt

A social media topic, likely related to a stock ticker symbol, experiencing high engagement and positive sentiment.

Insights #

Engagements: XXXXX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX +122%
1 Month: XXXXXXX -XX%
1-Year High: XXXXXXX on 2025-06-04
1-Year Low: XXX on 2025-06-01

Social Network X YouTube
Engagements XXXXX X

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX +799%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-05-25

Social Network X YouTube
Mentions XX X

Creators: XX #


Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $sgmt in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
1 Week: XXX -XX%
1 Month: XXXXX +1,149%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-05-25

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -X%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-05-29

Most Supportive Themes

Most Critical Themes

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXXXX XX% XX X%
YouTube X X% X X% X X%
Total XXX XX% XXXXX XX% XX X%

Top assets mentioned In the posts about $sgmt in the last XX hours

Single Collateral DAI (SAI) Sarepta Therapeutics, Inc. (SRPT) Eli Lilly and Company (LLY) Akropolis (AKRO) Marblex (MBX) Snowflake, Inc. (SNOW) Charles Schwab Corporation (SCHW) Newell Brands Inc (NWL) Bull Market (BULL) Braze, Inc. Class A Common Stock (BRZE)

Top topics mentioned In the posts about $sgmt in the last XX hours

googl, roma, qqq, spx, nvda, $tgan, nio, $mpu, $sai, $srpt, $dbgi, $revb, crcl, $auid, goog, baba, $swvl, $lly, $nmhi, mob, oscr, op, meta, le, spy, pltr, dv, watchlist, $eprx, coins ai, $etnb, $akro, cnr, $cdtx, akro, discord, $prme, mbx, $mbx, $snow, radar, acet, $iobt, $imab, $adag, $anvs, msft, $gtn, avgo, balance sheet, $laes, wmt, stocks, bon, bbai, $mctr, $nktr, mag, birk, asml, nem, $schw, nasdaq, alternative investment, $iqst, pep, $nwl, $bull, wsj, $1776hk, $brze, $hwkn, $algs, cai, $cai, next big, if you, $alny, alnylam pharmaceuticals inc, stocks healthcare, $ixhl, $dmac, pdsb, $ipsc, $xfor, $wint, $hkd, $27m, cuttingedge, nft, fwrd, apm, $mreo, $sviir, sats, phat, orgo, $phat, ticker, amzn

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Notable XX Week Highs Cont. from Part X $GS $GTES $ICE $IDXX $IESC $INDV $IPA $IVZ $IZEA $JBGS $JCI $LCTX $LIDF $LIF $LQDA $MCVT $MPU $MRUS $MTZ $MYRG $NEM $NPKI $NTWK $NVDA $OMF $PARA $PH $PLTR $PRIM $PVLA $PWR $R $RACE $RBKB $RL $RMD $RZLT $SAN $SCHW $SGMT Part X Cont. -"
@MarcJacksonLA on X 2025-07-25 17:57:40 UTC 7121 followers, 1045 engagements

"$SGMT is one i got into yesterday thought it might play out like $IREN but its starting to work"
@SayesTrading on X 2025-07-25 14:32:14 UTC XX followers, XXX engagements

"Lets gooo $CELU $UAVS $PAVS $INDO $HUSA $CNF $SITC $MGRX $BALN $XHG $DUO $NUWE $ROMA $FRES $FLGC $CJJD $SGMT $NNE $ENSV $TPET $SPCB $HUBC $PRZO $NVDA $HOLO $XPON $ZCMD $HWH $ICCT $MLGO $HOLO $DUO $WHLR $INDO $HUSA $HUBC $HKD $NMHI $REVB $DBGI"
@TradershubNinja on X 2025-07-25 12:17:27 UTC 3839 followers, XXX engagements

"$SGMT Sagimet Biosciences (NASDAQ:SGMT) traded higher on Thursday after Canaccord Genuity launched its coverage with a Buy recommendation citing the potential of its lead asset denifanstat targeted at a liver disease called metabolic dysfunction-associated steatohepatitis (MASH). With a 12-month price target of $XX Canaccord analyst Edward Nash argued that the California-based biotech stands out from its peers in the MASH space given its combination approach against the fatty liver disease. Sagimet is one of the more compelling names in the MASH space given their lead drug denifanstats"
@MarketMaestro1 on X 2025-07-24 15:56:22 UTC 27.5K followers, 2350 engagements